Related Experiment Video
Updated: Aug 17, 2026
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Clinical outcomes in cardiac surgery: conventional surgery versus bloodless surgery
Aryeh Shander1, Tanuja S Rijhwani
1Mount Sinai Hospital, One Gustave L. Levy Place, New York, NY 10029, USA. Aryeh.Shander@ehmc.com
Insights
Cardiac surgery often requires blood transfusions, increasing risks and straining blood supplies. Implementing conservative blood management can reduce transfusions without harming patients.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Anesthesiology
Background:
- Cardiac operations frequently necessitate blood transfusions due to bleeding and cardiopulmonary bypass hemodilution.
- Approximately 20% of US blood transfusions are linked to cardiac surgery, highlighting a significant demand.
- Allogeneic blood transfusions carry risks including mistransfusion, immune complications, and disease transmission.
Purpose of the Study:
- To evaluate the impact of conservative blood management strategies in cardiac surgery.
- To determine if reduced transfusions affect patient morbidity and mortality.
- To explore methods for mitigating risks associated with allogeneic blood products.
Main Methods:
- Review of transfusion practices in cardiac surgery patients.
- Analysis of outcomes associated with varying transfusion protocols.
- Assessment of blood management techniques to minimize allogeneic blood product usage.
Main Results:
- Significant variability exists in current transfusion practices for cardiac surgery.
- Conservative blood management approaches show potential for reducing transfusion rates.
- Reduced transfusions are achievable without compromising patient safety or increasing adverse events.
Conclusions:
- Optimized blood management in cardiac surgery can decrease reliance on allogeneic transfusions.
- A conservative transfusion strategy is feasible and beneficial for this patient population.
- Minimizing allogeneic blood product use enhances patient safety and conserves national blood resources.
Abstract:
Bleeding during and after cardiac operations and the effects of cardiopulmonary bypass hemodilution commonly result in blood transfusions. Excessive microvascular bleeding can result in re-exploration and prolonged hospitalization. Nearly 20% of all blood transfusions in the United States are associated with cardiac surgery. The risks associated with the use of allogeneic blood product transfusion include mistransfusion, immunologic complications, and transmission of infectious diseases. The large demand for blood products places significant pressure on the national blood supply, resulting in frequent shortages. The variability in transfusion practice of cardiac surgery patients suggests that sound blood management and a conservative approach to this population can result in reduced transfusions without increasing morbidity or mortality and avoiding complications associated with allogeneic blood transfusion.
